Vice Versa Event Management

Joint FMS/DSBS Meeting


Date and time

Tuesday November 1, 2016 at 09:00 to 16:00

Registration deadline

Monday October 24, 2016 at 12:00

Location

Radisson Blu Hotel Malmö
Östergatan 10
211 25 Malmö

Organizer

Vice Versa Event Management
+45 44231231
max@vice-versa.dk

Statistical analysis of risk and safety data

                                                 

The 2016 Joint FMS/DSBS Meeting is now open for registration.

Every second year the Swedish and Danish societies for biopharmaceutical/ medical statistics, FMS and DSBS, arrange a joint meeting. This year’s meeting will take place at the Radisson Blu Hotel in Malmö the 1st of November 2016.

Programme:
08.00-09.00  Registration and Breakfast
09.00-09.10  Welcome and Opening of Meeting
                      Paul Dickman, President of FMS
                      Charlotte Hindsberger, President of DSBS
09.10-10.00  Application of extreme value modelling to safety data from
                      clinical trials
                       Harry Southworth, Data Clarity Consulting Ltd., UK
10.00-10.20  Coffee
10.20-11.10  Use of survival analysis methods in the
                      assessment of safety
                      Per Kragh Andersen, Biostatistics, University of Copenhagen
11.10-12.00  Recent regulatory considerations on summarising safety
                      data from clinical trials
                      
Andrew Thomson, European Medicines Agency, UK
12.00-13.00  Lunch
13.00-13.30  Drug safety during pregnancies – Evaluation with register
                      based pharmacoepidemiology
                      Pär Karlsson, Centre for Pharmacoepidemiology,
                      Karolinska Institutet, Stockholm
13.30-14.00  Liraglutide and Cardiovascular Outcomes in Type 2
                      Diabetes
                       Søren Rasmussen, Novo Nordisk, Copenhagen
14.00-14.30  Modelling duration of diabetes in a design with matched
                      controls
                      Stefan Franzén, Centre of Registers Västra Götaland,
                      Gothenburg

14.30-14.50  Coffee
14.50-15.20  Statistical analysis of recurrent events, based on simple
                      frailty models, and extensions
                      Philip Hougaard, Lundbeck, Denmark
15.20-15.50  Latent class analysis for more effective exploration of
                      suspected adverse drug reactions
                      Niklas Norén, Uppsala Monitoring Centre
                      WHO Collaborating Centre for International Drug Monitoring,
                      Uppsala
15.50-16.00  Closing remarks
                      Paul Dickman, President of FMS
                      Charlotte Hindsberger, President of DSBS


For abstracts of all the presentations, please click here

Conference fee:
1500/750 DKK for industry/academia employees. The fee includes breakfast, lunch and coffee.

For further information about the meeting, please contact anyone in the organising committee:

         Gabriel Abreu (gabriel.abreu@astrazeneca.com)
         Birgitte Biilmann Rønn (bbr@novonordisk.com)
         Per Larsson (PerErikRoland.Larsson@ferring.com)
         Rebecca Zachariae Nielsen (rzn@lundbeck.com)
                   

Event Location

Organizer Contact Information

Vice Versa Event Management
+45 44231231
max@vice-versa.dk